References
- Harapan H, Itoh N, Yufika A, Winardi W, Keamg S, Te H, Megawati D, Hayati Z, Wagner A, Mudatsir M. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5):667–73. doi:https://doi.org/10.1016/j.jiph.2020.03.019.
- Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–34. doi:https://doi.org/10.1016/S1473-3099(20)30120-1.
- Thorlund K, Dron L, Park J, Hsu G, Forrest J, Mills E. A real-time dashboard of clinical trials for COVID-19. Lancet. 2020;2:e286–e287.
- Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, Lane HC, Memish Z, Oh MD, Sall AA, et al.; Strategic, W. H. O.; Technical Advisory Group for Infectious, H. COVID-19: towards controlling of a pandemic. Lancet. 2020;395(10229):1015–18. doi:https://doi.org/10.1016/S0140-6736(20)30673-5.
- Thanh Le T, Andreadakis Z, Kumar A, Gomez Roman R, Tollefsen S, Saville M, Mayhew S. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305–06. doi:https://doi.org/10.1038/d41573-020-00073-5.
- Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. N Engl J Med. 2020;382(21):1969–73. In press. doi:https://doi.org/10.1056/NEJMp2005630.
- Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020;395(10240):1845–54. doi:https://doi.org/10.1016/S0140-6736(20)31208-3.
- Hanney SR, Wooding S, Sussex J, Grant J, From COVID-19. research to vaccine application: why might it take 17 months not 17 years and what are the wider lessons? Health Res Policy Syst. 2020;18(1):61. doi:https://doi.org/10.1186/s12961-020-00571-3.
- Harapan H, Anwar S, Bustamam A, Radiansyah A, Angraini P, Fasli R, Salwiyadi S, Bastian RA, Oktiviyari A, Akmal I, et al. Willingness to pay for a dengue vaccine and its associated determinants in Indonesia: a community-based, cross-sectional survey in Aceh. Acta Trop. 2017;166:249–56. doi:https://doi.org/10.1016/j.actatropica.2016.11.035.
- Hadisoemarto PF, Castro MC. Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in Bandung, Indonesia. PLoS Negl Trop Dis. 2013;7:e2427.
- Palanca-Tan R. The demand for a dengue vaccine: a contingent valuation survey in Metro Manila. Vaccine. 2008;26(7):914–23. doi:https://doi.org/10.1016/j.vaccine.2007.12.011.
- Lee JS, Mogasale V, Lim JK, Carabali M, Sirivichayakul C, Anh DD, Lee KS, Thiem VD, Limkittikul K, Tho Le H, et al. A multi-country study of the household willingness-to-pay for dengue vaccines: household surveys in Vietnam, Thailand, and Colombia. PLoS Negl Trop Dis. 2015;9(6):e0003810. doi:https://doi.org/10.1371/journal.pntd.0003810.
- Rajamoorthy Y, Radam A, Taib NM, Rahim KA, Munusamy S, Wagner AL, Mudatsir M, Bazrbachi A, Harapan H. Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: a cross-sectional household survey. PLoS One. 2019;14(4):e0215125. doi:https://doi.org/10.1371/journal.pone.0215125.
- Fu C, Wei Z, Pei S, Li S, Sun S, Liu P. Acceptance and preference for COVID-19 vaccination in health-care workers (HCWs). medRxiv Preprint. 2020. doi:https://doi.org/10.1101/2020.04.09.20060103.
- Berghea F, Berghea CE, Abobului M, Vlad VM. Willingness to pay for a for a potential vaccine against SARS-CoV-2/COVID-19 among adult persons; 2020. doi:https://doi.org/10.21203/rs.3.rs-32595/v1
- Garcia LY, Cerda AA. Contingent assessment of the COVID-19 vaccine. Vaccine. 2020;38(34):5424–29. doi:https://doi.org/10.1016/j.vaccine.2020.06.068.
- Wong LP, Alias H, Wong P-F, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020;1–11. In press. doi:https://doi.org/10.1080/21645515.2020.1790279.
- Mudatsir M, Anwar S, Fajar JK, Yufika A, Ferdian MN, Salwiyadi S, Imanda AS, Azhars R, Ilham D, Timur AU. Willingness-to-pay for a hypothetical Ebola vaccine in Indonesia: a cross-sectional study in Aceh. F1000Research. 2019;8(1441):1441. doi:https://doi.org/10.12688/f1000research.20144.1.
- Ughasoro MD, Esangbedo DO, Tagbo BN, Mejeha IC. Acceptability and willingness-to-pay for a hypothetical ebola virus vaccine in Nigeria. PLoS Negl Trop Dis. 2015;9(6):e0003838. doi:https://doi.org/10.1371/journal.pntd.0003838.
- Sarmento TTR, Godoi IP, Reis EA, Godman B, Ruas CM. Consumer willingness to pay for a hypothetical chikungunya vaccine in Brazil and the implications. In Expert Rev Pharmacoecon Outcomes Res; 2019. p. 1–8. doi:https://doi.org/10.1080/14737167.2020.1703181.
- Painter JE, von Fricken ME, Viana de OMS, DiClemente RJ. Willingness to pay for an Ebola vaccine during the 2014-2016 ebola outbreak in West Africa: results from a U.S. National sample. Hum Vaccin Immunother. 2018;14(7):1665–71. doi:https://doi.org/10.1080/21645515.2018.1423928.
- Muniz Junior RL, Godoi IP, Reis EA, Garcia MM, Guerra-Junior AA, Godman B, Ruas CM. Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications. Expert Rev Pharmacoecon Outcomes Res. 2019;19(4):473–82. doi:https://doi.org/10.1080/14737167.2019.1552136.
- Harapan H, Mudatsir M, Yufika A, Nawawi Y, Wahyuniati N, Anwar S, Yusri F, Haryanti N, Wijayanti NP, Rizal R, et al. Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: a cross-sectional study in Indonesia. Vaccine. 2019;37(11):1398–406. doi:https://doi.org/10.1016/j.vaccine.2019.01.062.
- Yeo HY, Shafie AA. The acceptance and willingness to pay (WTP) for hypothetical dengue vaccine in Penang, Malaysia: a contingent valuation study. Cost Eff Resour Alloc. 2018;16:60. doi:https://doi.org/10.1186/s12962-018-0163-2.
- Nguyen LH, Tran BX, Do CD, Hoang CL, Nguyen TP, Dang TT, Thu Vu G, Tran TT, Latkin CA, Ho CS, et al. Feasibility and willingness to pay for dengue vaccine in the threat of dengue fever outbreaks in Vietnam. Patient Prefer Adherence. 2018;12:1917–26.
- Bishai D, Pariyo G, Ainsworth M, Hill K. Determinants of personal demand for an AIDS vaccine in Uganda: contingent valuation survey. Bull World Health Organ. 2004;82:652–60.
- Birhane MG, Miranda ME, Dyer JL, Blanton JD, Recuenco S. Willingness to pay for dog rabies vaccine and registration in Ilocos Norte, Philippines (2012). PLoS Negl Trop Dis. 2016;10(3):e0004486. doi:https://doi.org/10.1371/journal.pntd.0004486.
- Boyle J. Contingent valuation in practice. Dordrecht, Netherlands: Springer; 2017. p. 83–131.
- Boissay F, Rungcharoenkitkul P. Macroeconomic effects of Covid-19: an early review. Bank for International Settlements; 2020 [accessed 17 Jul 2020] https://www.bis.org/publ/bisbull07.pdf.
- Masters N, Shih S, Bukoff A, Akel K, Kobayashi L, Miller A, Harapan H, Lu Y, AL W. Social distancing in response to the novel coronavirus (COVID-19) in the United States; PloS ONE; 2020.
- O’Brien RM. A caution regarding rules of thumb for variance inflation factors. Qual Quant. 2007;41(5):673–90. doi:https://doi.org/10.1007/s11135-006-9018-6.
- Glejser H. A new test for heteroskedasticity. J Am Stat Assoc. 1969;64(325):316. doi:https://doi.org/10.1080/01621459.1969.10500976.
- Yap BW, Sim CH. Comparisons of various types of normality tests. J Stat Comput Simul. 2011;81(12):2141–55. doi:https://doi.org/10.1080/00949655.2010.520163.
- Sauerborn R, Gbangou A, Dong H, Przyborski JM, Lanzer M. Willingness to pay for hypothetical malaria vaccines in rural Burkina Faso. Scand J Public Health. 2005;33(2):146–50. doi:https://doi.org/10.1080/14034940510005743.
- Hansen KS, Pedrazzoli D, Mbonye A, Clarke S, Cundill B, Magnussen P, Yeung S. Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono District, Uganda. Health Policy Plan. 2013;28(2):185–96. doi:https://doi.org/10.1093/heapol/czs048.
- Feng C, Wang H, Lu N, Chen T, He H, Lu Y, Tu XM. Log-transformation and its implications for data analysis. Shanghai Arch Psychiatry. 2014;26:105–09.
- Yang J. Interpreting coefficients in regression with log-transformed variables. Cornell Stat Consulting Unit. 2012. [accessed 1 Mar 2019] https://www.cscu.cornell.edu/news/archive.php
- Lloyd J, Coronavirus: can herd immunity protect us from COVID-19?; 2020 [accessed 14 May 2020] https://www.sciencefocus.com/news/coronavirus-can-herd-immunity-protect-us-from-covid-19/.
- Arbiol J, Yabe M, Nomura H, Borja M, Gloriani N, Yoshida S-I. Using discrete choice modeling to evaluate the preferences and willingness to pay for leptospirosis vaccine. Hum Vaccin Immunother. 2015;11(4):1046–56. doi:https://doi.org/10.1080/21645515.2015.1010901.
- Vo TQ, Tran QV, Vo NX. Customers’ preferences and willingness to pay for a future dengue vaccination: a study of the empirical evidence in Vietnam. Patient Prefer Adherence. 2018;12:2507–15. doi:https://doi.org/10.2147/PPA.S188581.
- Harapan H, Anwar S, Ferdian M, Salwiyadi S, Imanda A, Azhars R, Fika D, Ilham D, Timur A, Sahputri J, et al. Public acceptance of a hypothetical Ebola virus vaccine in Aceh, Indonesia: A hospital-based survey. Asian Pac J Trop Dis. 2017;7(4):193–98. doi:https://doi.org/10.12980/apjtd.7.2017D6-386.
- Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Front Public Health. 2020; 8: 381. doi: https://doi.org/10.3389/fpubh.2020.00381.
- Vasilevska M, Ku J, Fisman DN. Factors associated with healthcare worker acceptance of vaccination: A systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2014;35(6):699–708. doi:https://doi.org/10.1086/676427.
- Nguyen TTM, Lafond KE, Nguyen TX, Tran PD, Nguyen HM, Ha VTC, Do TT, Ha NT, Seward JF, McFarland JW. Acceptability of seasonal influenza vaccines among health care workers in Vietnam in 2017. Vaccine. 2020;38(8):2045–50. doi:https://doi.org/10.1016/j.vaccine.2019.12.047.
- Rajamoorthy Y, Radam A, Taib NM, Rahim KA, Wagner AL, Mudatsir M, Munusamy S, Harapan H. The relationship between perceptions and self-paid hepatitis B vaccination: A structural equation modeling approach. PLoS One. 2018;13(12):e0208402. doi:https://doi.org/10.1371/journal.pone.0208402.
- Harapan H, Anwar S, Setiawan AM, Sasmono RT, Aceh Dengue S. Dengue vaccine acceptance and associated factors in Indonesia: A community-based cross-sectional survey in Aceh. Vaccine. 2016;34(32):3670–75. doi:https://doi.org/10.1016/j.vaccine.2016.05.026.
- Thomson A, Robinson K, Vallee-Tourangeau G. The 5As: A practical taxonomy for the determinants of vaccine uptake. Vaccine. 2016;34(8):1018–24. doi:https://doi.org/10.1016/j.vaccine.2015.11.065.
- Data portal, digital 2020: Indonesia; 2020. [accessed 14 Jul 2020] https://datareportal.com/reports/digital-2020-indonesia.
- Harapan H, Setiawan AM, Yufika A, Anwar S, Wahyuni S, Asrizal FW, Sufri MR, Putra RP, Wijayanti NP, Salwiyadi S, et al. Knowledge of human monkeypox viral infection among general practitioners: a cross-sectional study in Indonesia. Pathog Glob Health. 2020;114(2):68–75. doi:https://doi.org/10.1080/20477724.2020.1743037.
- Harapan H, Setiawan AM, Yufika A, Anwar S, Wahyuni S, Asrizal FW, Sufri MR, Putra RP, Wijayanti NP, Salwiyadi S, et al. Confidence in managing human monkeypox cases in Asia: a cross-sectional survey among general practitioners in Indonesia. Acta Trop. 2020;206:105450. doi:https://doi.org/10.1016/j.actatropica.2020.105450.
- Victoria A, Rata-rata Pendapatan Penduduk Indonesia Setahun Rp 59 Juta; 2020. [accessed 14 Jul 2020] https://katadata.co.id/berita/2020/02/05/rata-rata-pendapatan-penduduk-indonesia-setahun-rp-59-juta.
- Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 vaccine in southeast Asia: a cross-sectional study in Indonesia. Fronti Public Health. 2020;8:381. doi:https://doi.org/10.3389/fpubh.2020.00381.